Your session is about to expire
← Back to Search
Cervical Cancer Screen-and-Treat Strategies for Cervical Cancer (ACCESS Trial)
N/A
Recruiting
Led By Gregory Aarons, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women living with HIV
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after enrollment
Awards & highlights
ACCESS Trial Summary
This trial aims to increase cervical cancer screening & treatment for women living with HIV in Nigeria, improving health & life expectancy.
Who is the study for?
This trial is for women living with HIV in certain low- and middle-income countries. It aims to improve cervical cancer screening and treatment by using existing HIV care infrastructure.Check my eligibility
What is being tested?
The ACCESS study compares two approaches: 'Core' strategies versus 'Core+' enhanced strategies, to integrate cervical cancer screen-and-treat services into HIV programs, assessing effectiveness through a cluster randomized design.See study design
What are the potential side effects?
Since the interventions involve implementation strategies rather than medications, traditional side effects are not applicable. However, there may be indirect impacts on patient experience based on how services are delivered.
ACCESS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowACCESS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reach
Sustainment
Secondary outcome measures
CCST Effectiveness
ACCESS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Core+ Enhanced Implementation StrategiesExperimental Treatment1 Intervention
Includes all of the Core implementation strategies and adds:
5. Community engagement using Health Beginning Initiative Model
6. Smart Cards to facilitate patient engagement
Group II: Core Implementation StrategiesActive Control2 Interventions
Core Implementation Strategies
Ongoing consultation
Educational meetings
Strengthen referral system
Prepare patients to be active participants
Find a Location
Who is running the clinical trial?
University of Nigeria NsukkaOTHER
1 Previous Clinical Trials
3,744 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,121 Previous Clinical Trials
1,518,488 Total Patients Enrolled
Gregory Aarons, PhDPrincipal InvestigatorUniversity of California, San Diego
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are geriatric individuals invited to participate in this experiment?
"As indicated by the trial's inclusion criteria, only patients aged 25 to 65 can participate. There are 72 clinical trials available for those under 18 and 569 options accessible to individuals over the age of 65."
Answered by AI
Does this investigation have any open slots for participants?
"The data hosted on clinicaltrials.gov indicates that this medical study, initially posted November 13th 2023, is not currently seeking participants. However, there are 659 other studies that are actively enrolling patients at the moment."
Answered by AI
Share this study with friends
Copy Link
Messenger